Go Pro
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free MLSS Stock Alerts

Milestone Scientific (MLSS) Competitors

Milestone Scientific logo
$0.38 -0.03 (-7.58%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.37 0.00 (-1.06%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

MLSS vs. KRMD, OWLT, INGN, APYX, and CNXU

Should you buy Milestone Scientific stock or one of its competitors? Milestone Scientific's main competitors and comparable companies include KORU Medical Systems (KRMD), Owlet (OWLT), Inogen (INGN), Apyx Medical (APYX), and Conexeu Sciences (CNXU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Milestone Scientific compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

KORU Medical Systems has a beta of 0.39, suggesting that its stock price is 61% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

KORU Medical Systems currently has a consensus price target of $7.00, suggesting a potential upside of 136.49%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 164.55%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

KORU Medical Systems has higher revenue and earnings than Milestone Scientific. KORU Medical Systems is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.31-$2.64M-$0.04N/A
Milestone Scientific$9.42M3.64-$6.93M-$0.04N/A

In the previous week, KORU Medical Systems and KORU Medical Systems both had 2 articles in the media. KORU Medical Systems' average media sentiment score of 0.30 beat Milestone Scientific's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Milestone Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems has a net margin of -4.03% compared to Milestone Scientific's net margin of -52.01%. KORU Medical Systems' return on equity of -10.63% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
Milestone Scientific -52.01%-60.26%-40.23%

Summary

KORU Medical Systems beats Milestone Scientific on 9 of the 14 factors compared between the two stocks.

How does Milestone Scientific compare to Owlet?

Milestone Scientific (NYSE:MLSS) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Milestone Scientific has higher earnings, but lower revenue than Owlet. Milestone Scientific is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$9.42M3.64-$6.93M-$0.04N/A
Owlet$105.70M1.39-$39.68M-$0.75N/A

Milestone Scientific has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Owlet has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market.

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by company insiders. Comparatively, 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Milestone Scientific currently has a consensus target price of $1.00, indicating a potential upside of 164.55%. Owlet has a consensus target price of $15.00, indicating a potential upside of 197.62%. Given Owlet's higher probable upside, analysts clearly believe Owlet is more favorable than Milestone Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Milestone Scientific had 1 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Milestone Scientific and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Milestone Scientific's score of 0.00 indicating that Owlet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Milestone Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Owlet has a net margin of -8.61% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Owlet -8.61%-601.24%-15.96%

Summary

Owlet beats Milestone Scientific on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Inogen?

Inogen (NASDAQ:INGN) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 164.55%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

89.9% of Inogen shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Inogen had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 6 mentions for Inogen and 2 mentions for Milestone Scientific. Inogen's average media sentiment score of 0.33 beat Milestone Scientific's score of 0.00 indicating that Inogen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inogen
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Milestone Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inogen has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

Milestone Scientific has lower revenue, but higher earnings than Inogen. Milestone Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inogen$348.67M0.45-$22.75M-$0.90N/A
Milestone Scientific$9.42M3.64-$6.93M-$0.04N/A

Inogen has a net margin of -6.94% compared to Milestone Scientific's net margin of -52.01%. Inogen's return on equity of -13.17% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Inogen-6.94% -13.17% -8.36%
Milestone Scientific -52.01%-60.26%-40.23%

Summary

Inogen beats Milestone Scientific on 9 of the 17 factors compared between the two stocks.

How does Milestone Scientific compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Milestone Scientific has lower revenue, but higher earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.84M2.03-$11.21M-$0.20N/A
Milestone Scientific$9.42M3.64-$6.93M-$0.04N/A

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 154.90%. Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 164.55%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Apyx Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Apyx Medical has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Apyx Medical had 11 more articles in the media than Milestone Scientific. MarketBeat recorded 13 mentions for Apyx Medical and 2 mentions for Milestone Scientific. Apyx Medical's average media sentiment score of 0.29 beat Milestone Scientific's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Apyx Medical
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Milestone Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Apyx Medical has a net margin of -14.78% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Apyx Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-14.78% -76.60% -13.91%
Milestone Scientific -52.01%-60.26%-40.23%

Summary

Apyx Medical beats Milestone Scientific on 10 of the 17 factors compared between the two stocks.

How does Milestone Scientific compare to Conexeu Sciences?

Milestone Scientific (NYSE:MLSS) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Conexeu Sciences has lower revenue, but higher earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Conexeu Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$9.42M3.64-$6.93M-$0.04N/A
Conexeu SciencesN/AN/A-$3.92M-$0.40N/A

Milestone Scientific presently has a consensus price target of $1.00, indicating a potential upside of 164.55%. Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 545.16%. Given Conexeu Sciences' higher probable upside, analysts clearly believe Conexeu Sciences is more favorable than Milestone Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Conexeu Sciences
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Milestone Scientific had 1 more articles in the media than Conexeu Sciences. MarketBeat recorded 2 mentions for Milestone Scientific and 1 mentions for Conexeu Sciences. Milestone Scientific's average media sentiment score of 0.00 equaled Conexeu Sciences'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Milestone Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Conexeu Sciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Conexeu Sciences has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Conexeu Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Conexeu Sciences N/A -200.20%-177.26%

5.8% of Milestone Scientific shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Milestone Scientific beats Conexeu Sciences on 9 of the 12 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MLSS vs. The Competition

Export
MetricMilestone ScientificHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$34.26M$5.43B$7.14B$22.66B
Dividend YieldN/A1.80%2.53%3.73%
P/E Ratio-5.4024.90275.9727.75
Price / Sales3.6484.79672.8898.91
Price / CashN/A32.4377.6038.88
Price / Book3.445.7310.934.64
Net Income-$6.93M$152.68M$3.51B$1.08B
7 Day Performance-7.96%-1.71%-2.00%-1.06%
1 Month Performance-19.39%-4.81%-6.15%-5.49%
1 Year Performance-13.90%1.08%7.44%5.13%

Milestone Scientific Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLSS
Milestone Scientific
1.3054 of 5 stars		$0.38
-7.6%		$1.00
+164.6%		-16.0%$34.26M$9.42MN/A15
KRMD
KORU Medical Systems
3.6612 of 5 stars		$3.21
-1.8%		$7.00
+118.1%		-21.7%$147.45M$45.11MN/A73
OWLT
Owlet
3.2129 of 5 stars		$5.02
-1.1%		$15.00
+199.0%		-40.4%$147.28M$114.41MN/A114
INGN
Inogen
1.1868 of 5 stars		$5.36
+2.5%		N/A-30.0%$142.24M$348.67MN/A753
APYX
Apyx Medical
2.8427 of 5 stars		$2.96
+4.6%		$6.60
+123.0%		+22.0%$124.69M$58.42MN/A205

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel